Statements (68)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:biotechnology
|
| gptkbp:acquisition |
Acquired by private equity firm
|
| gptkbp:awards |
received multiple industry awards
|
| gptkbp:ceo |
gptkb:Dr._Klaus_W._W._Schaefer
|
| gptkbp:clinical_trial |
conducts clinical trials globally
invests in clinical research focus on clinical research excellence |
| gptkbp:collaborations |
collaborates with global research networks
|
| gptkbp:community_engagement |
supports local communities
|
| gptkbp:community_support |
supports health initiatives
|
| gptkbp:conference |
participates in international conferences
|
| gptkbp:cultural_diversity |
committed to diversity and inclusion
|
| gptkbp:customer_base |
healthcare providers
hospitals and clinics blood banks |
| gptkbp:customer_feedback |
values customer feedback
|
| gptkbp:employees |
approximately 1,500
|
| gptkbp:financials |
gptkb:public_company
|
| gptkbp:focus |
therapeutics for infectious diseases
therapeutics for hematology therapeutics for immunology |
| gptkbp:founded |
1946
|
| gptkbp:global_presence |
operates in over 100 countries
|
| gptkbp:grants |
provides research grants
|
| gptkbp:has_culture |
promotes a collaborative culture
|
| gptkbp:headcount |
over 1,500
|
| gptkbp:headquarters |
gptkb:Dreieich,_Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
Biotest AG
|
| gptkbp:industry |
gptkb:pharmaceuticals
|
| gptkbp:innovation |
focus on innovative therapies
|
| gptkbp:invention |
holds numerous patents
|
| gptkbp:investment |
attracts institutional investors
|
| gptkbp:market |
global
conducts market research |
| gptkbp:market_launch |
regularly launches new products
|
| gptkbp:marketing_strategy |
expansion into emerging markets
|
| gptkbp:mission |
improving patient care
|
| gptkbp:partnerships |
collaborations with universities
collaborations with research institutions strategic partnerships with biotech firms |
| gptkbp:product |
focus on product development
|
| gptkbp:product_quality |
strict quality control measures
|
| gptkbp:products |
immunoglobulins
albumin coagulation factors plasma proteins |
| gptkbp:regulatory_compliance |
gptkb:European_Medicines_Agency
gptkb:U._S._Food_and_Drug_Administration ensures regulatory compliance |
| gptkbp:research_and_development |
clinical trials
|
| gptkbp:research_focus |
biopharmaceuticals
plasma-derived therapies |
| gptkbp:safety |
committed to patient safety
|
| gptkbp:stock_symbol |
BIO
|
| gptkbp:subsidiaries |
gptkb:Biotest_Pharma
gptkb:Biotest_USA |
| gptkbp:supply_chain |
sustainable supply chain practices
global supply chain management |
| gptkbp:sustainability |
social responsibility
environmental responsibility economic responsibility |
| gptkbp:training |
provides employee training programs
|
| gptkbp:treatment |
focus on improving clinical outcomes
|
| gptkbp:vision |
leading in biotherapeutics
|
| gptkbp:website |
www.biotest.com
|
| gptkbp:bfsParent |
gptkb:Kedrion_S.p._A.
gptkb:Grifols |
| gptkbp:bfsLayer |
6
|